New hope for kids with tough blood cancers: modified transplant trial begins
NCT ID NCT07052370
Summary
This early-stage trial is testing the safety of a new type of blood cell transplant for children and young adults (up to age 21) with high-risk blood cancers. The treatment uses specially processed cells from a partially matched family donor, followed by an infusion of immune cells, to try to prevent the cancer from coming back. The main goal is to see if this multi-step approach is safe and feasible for patients who don't have a fully matched donor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St. Jude Children's Research Hospital
RECRUITINGMemphis, Tennessee, 38105, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.